Soumit Roy analyst JONESTRADING

Currently, out of the existing stock ratings of Soumit Roy - 12 which are a Buy (85.71%), 1 which are a Hold (7.14%), 1 which are a Sell (7.14%)

Soumit Roy

Work Performance Price Targets & Ratings Chart

Analyst Soumit Roy works at JONESTRADING and is covering the Healthcare sector with 25 price targets and ratings displayed on 6 stocks.

Soumit Roy's average stock forecast success ratio is 26.67% with an average time for price targets to be met of 55 days.

Most recent stock forecast was given on DCPH, Deciphera Pharmaceuticals at 06-Jan-2023.

Wall Street Analyst Soumit Roy

Analyst best performing recommendations are on AVEO (AVEO PHARMACEUTICALS).
The best stock recommendation documented was for AVEO (AVEO PHARMACEUTICALS) at 3/14/2022. The price target of $12 was fulfilled within 218 days with a profit of $7.41 (161.44%) receiving and performance score of 7.41.

Average potential price target upside

DCPH Deciphera Pharmaceuticals INFI Infinity Pharmaceuticals AVEO AVEO Pharmaceuticals SAVA Cassava Sciences SBTX Silverback Therapeutics IKT

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

20

$7.54 (60.51%)

18

1 months 17 days ago

2/5 (40%)

$12.76 (36.55%)

22

Buy

25

$12.54 (100.64%)

25

1 months 17 days ago

3/8 (37.5%)

$13.97 (72.54%)

118

Buy

23

$10.54 (84.59%)

23

3 months 22 days ago

1/5 (20%)

$6.76 (32.05%)

34

Buy

30

$17.54 (140.77%)

28

7 months 19 days ago

7/12 (58.33%)

$3 (13.99%)

199

Buy

30

$17.54 (140.77%)

25

8 months 2 days ago

0/2 (0%)

$10.69 (63.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Soumit Roy?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart